.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Chubb
Accenture
Deloitte
US Department of Justice
Teva
Novartis
Harvard Business School
Express Scripts
Farmers Insurance

Generated: June 22, 2017

DrugPatentWatch Database Preview

Chlortetracycline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for chlortetracycline hydrochloride and what is the scope of chlortetracycline hydrochloride patent protection?

Chlortetracycline hydrochloride
is the generic ingredient in one branded drug marketed by Lederle and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for chlortetracycline hydrochloride.

Summary for Generic Name: chlortetracycline hydrochloride

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list12
Bulk Api Vendors: see list108
Clinical Trials: see list2,244
Patent Applications: see list7,346
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:chlortetracycline hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle
AUREOMYCIN
chlortetracycline hydrochloride
OINTMENT;OPHTHALMIC050404-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
QuintilesIMS
Citi
McKesson
McKinsey
Covington
Queensland Health
Chinese Patent Office
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot